Beatriz Martin Antonio Profile
Beatriz Martin Antonio

@Beatriz15995013

Followers
133
Following
769
Statuses
293

Researcher in CAR-T cell immunotherapy. Cancer Immunotherapy group at ISCIII https://t.co/RMWZd1QG8P https://t.co/uUVbAzdnQG

Madrid
Joined September 2022
Don't wanna be here? Send us removal request.
@Beatriz15995013
Beatriz Martin Antonio
4 days
RT @ValentinOrtizMD: Truly honoured to receive the 5th EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2025…
0
11
0
@Beatriz15995013
Beatriz Martin Antonio
4 days
1
0
1
@Beatriz15995013
Beatriz Martin Antonio
5 days
RT @MM_Hub: CONGRESS | #CART25 | PRESENTATION Carlos Fernández de Larrea @fdezdelarrea @hospitalclinic highlights results from a study of A…
0
6
0
@Beatriz15995013
Beatriz Martin Antonio
5 days
RT @jitcancer: New #JITC commentary: What’s in a name? Memory NK cells for cancer immunotherapy
0
6
0
@Beatriz15995013
Beatriz Martin Antonio
5 days
RT @7eyeblink: ARI002h keeps growing up!! Results in AL amyloidosis, efficacy in soft tissue plasmacytoma and impact of 2nd boost of CART!…
0
10
0
@Beatriz15995013
Beatriz Martin Antonio
5 days
0
10
0
@Beatriz15995013
Beatriz Martin Antonio
7 days
RT @LabWaggoner: Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation @…
0
16
0
@Beatriz15995013
Beatriz Martin Antonio
7 days
RT @jitcancer: Let’s look at #JITC article “Preclinical development of 3 novel CARs targeting CD79b for the treatment of NHL & characteriza…
0
3
0
@Beatriz15995013
Beatriz Martin Antonio
7 days
@jitcancer @SaludISCIII Thank you jitccancer. JITC is an excellent journal to read the latest advances in cancer immunotherapy. It is a great honor that our work developing CART79b cells has been accepted at JITC.This way, our results can reach a high number of researchers working in this field.
0
0
4
@Beatriz15995013
Beatriz Martin Antonio
7 days
RT @jitcancer: Meet the Author: Dr. Beatriz Martín-Antonio (@Beatriz15995013), a PI from @SaludISCIII, & senior author of “Preclinical deve…
0
1
0
@Beatriz15995013
Beatriz Martin Antonio
19 days
RT @LabWaggoner: Mitochondrial respiratory complex III sustains IL-10 production in macrophages and promotes tumor-mediated immune evasion…
0
15
0
@Beatriz15995013
Beatriz Martin Antonio
20 days
RT @LabWaggoner: A 37-Color Spectral Flow Cytometric Panel to Assess Transcription Factors and Chemokine Receptors in Human Intestinal Lymp…
0
44
0
@Beatriz15995013
Beatriz Martin Antonio
22 days
RT @c_garciavidal: Seguimos buscando un/a médico joven q quiera hacer la tesis doctoral en infecciones en pacientes inmunodeprimidos. Inter…
0
20
0
@Beatriz15995013
Beatriz Martin Antonio
25 days
RT @Cancer_Cell: Plasma cell and cancer stem cell crosstalk in glioblastoma
Tweet media one
0
52
0
@Beatriz15995013
Beatriz Martin Antonio
25 days
RT @jitcancer: New #JITC article: Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid…
0
4
0
@Beatriz15995013
Beatriz Martin Antonio
26 days
RT @jitcancer: New #JITC commentary: Weal and woe of interleukin-18 in the T cell therapy of cancer @ChristophKesse
0
4
0
@Beatriz15995013
Beatriz Martin Antonio
27 days
RT @antonioper_mar: La Paz testea el tándem trasplante alogénico y CAR-T en leucemia infantil
0
22
0
@Beatriz15995013
Beatriz Martin Antonio
29 days
0
0
0
@Beatriz15995013
Beatriz Martin Antonio
30 days
RT @jitcancer: New #JITC case report: Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a…
0
3
0